Tumor Cell Nanovaccines Based on Genetically Engineered Antibody‐Anchored Membrane

Y Li, H Zhang, R Wang, Y Wang, R Li, M Zhu… - Advanced …, 2023 - Wiley Online Library
Despite the promise in whole‐tumor cell vaccines, a key challenge is to overcome the lack of
costimulatory signals. Here, agonistic‐antibody‐boosted tumor cell nanovaccines are …
被引用次数：24 相关文章

Tumor Cell Nanovaccines Based on Genetically Engineered Antibody-Anchored Membrane

Y Li, H Zhang, R Wang, Y Wang, R Li… - Advanced …, 2023 - pubmed.ncbi.nlm.nih.gov
Despite the promise in whole-tumor cell vaccines, a key challenge is to overcome the lack of
costimulatory signals. Here, agonistic-antibody-boosted tumor cell nanovaccines are …

Tumor Cell Nanovaccines based on Genetically Engineered Antibody-anchored Membrane.

Y Li, H Zhang, R Wang, Y Wang, R Li… - … (Deerfield Beach, Fla …, 2023 - europepmc.org
Despite the promise in whole-tumor cell vaccines, a key challenge is to overcome the lack of
co-stimulatory signals. Here, we reported agonistic antibody-boosted tumor cell …

Tumor Cell Nanovaccines Based on Genetically Engineered Antibody-Anchored Membrane

Y Li, H Zhang, R Wang, Y Wang, R Li… - Advanced …, 2023 - ui.adsabs.harvard.edu
Despite the promise in whole-tumor cell vaccines, a key challenge is to overcome the lack of
costimulatory signals. Here, agonistic-antibody-boosted tumor cell nanovaccines are …

Tumor Cell Nanovaccines Based on Genetically Engineered Antibody‐Anchored Membrane

Y Li, H Zhang, R Wang, Y Wang, R Li, M Zhu… - Advanced …, 2023 - infona.pl
Despite the promise in whole‐tumor cell vaccines, a key challenge is to overcome the lack of
costimulatory signals. Here, agonistic‐antibody‐boosted tumor cell nanovaccines are …

Tumor Cell Nanovaccines Based on Genetically Engineered Antibody‐Anchored Membrane

Y Li, H Zhang, R Wang, Y Wang, R Li, M Zhu… - Advanced …, 2023 - infona.pl
Despite the promise in whole‐tumor cell vaccines, a key challenge is to overcome the lack of
costimulatory signals. Here, agonistic‐antibody‐boosted tumor cell nanovaccines are …